(Q46974506)

27 December 2017

title

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis (English)

1 reference

27 December 2017

author

Mohsen Khademi

2

1 reference

27 December 2017

Santo Caracappa

6

1 reference

27 December 2017

Tommy Olsson

9

object named as

Olsson T

1 reference

ORCID Public Data File 2021

27 December 2017

1 reference

author name string

Di Marco R

1

1 reference

27 December 2017

Wallstrom E

3

1 reference

27 December 2017

Iacobaeus E

4

1 reference

27 December 2017

Salvaggio A

5

1 reference

27 December 2017

Papoian R

7

1 reference

27 December 2017

Nicoletti F

8

1 reference

27 December 2017

publication date

1 June 2001

1 reference

27 December 2017

Journal of Neuroimmunology

published in

1 reference

27 December 2017

volume

116

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

168-177

1 reference

27 December 2017

Role of Interleukin 6 and Transforming Growth Factor–β in the Induction of Depressed Splenocyte Responses Following Sepsis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Defective inflammatory response in interleukin 6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interleukin-6 is elevated in plasma in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interferon beta therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Immunologic Mechanisms and Therapy in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Multiple sclerosis: a unique immunopathological syndrome of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

The cytokine storm in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

IL-6 detection in multiple sclerosis brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900301-0

7 January 2021

10.1016/S0165-5728(01)00301-0

Identifiers

DOI

1 reference

27 December 2017

release_6sfhja3npbfcfmkm7zglus5ija

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6sfhja3npbfcfmkm7zglus5ija

24 November 2022

mapped directly with Wikidata item

PubMed ID

11438171

1 reference

27 December 2017